Document is current
Any future updates will be listed below
-
Authors
Papanikolaou, Christina
Economopoulou, Panagiota
Spathis, Aris https://orcid.org/0000-0001-8867-3661
Kotsantis, Ioannis
Gavrielatou, Niki
Anastasiou, Maria
Moutafi, Myrto
Kyriazoglou, Anastasios
Foukas, George-Romanos P.
Lelegiannis, Ioannis M.
Rimm, David https://orcid.org/0000-0001-5820-4397
Panayiotides, Ioannis
Foukas, Periklis
Souliotis, Vassilis L. https://orcid.org/0000-0002-2945-1329
Psyrri, Amanda
-
Funding
Funding for this research was provided by:
Hellenic Society of Medical Oncology (N/A)
- License Information
-
More Information
Article History
Received: 28 April 2024
Revised: 28 March 2025
Accepted: 14 April 2025
First Online: 23 May 2025
Competing interests
: Amanda Psyrri has received honoraria and research funding from BMS, MSD, Roche, Pfizer, Merck Serono. AstraZeneca, Ipsen. She has also received research support from KURA Oncology.
: The study was approved by the Ethical Committee of Attikon Hospital, Athens, Greece. All participants gave informed consent to participate in the study. The study was conducted according to the Declaration of Helsinki.
